These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
237 related items for PubMed ID: 8799621
1. Cardiovascular disease and its risk factors in IDDM in Europe. EURODIAB IDDM Complications Study Group. Koivisto VA, Stevens LK, Mattock M, Ebeling P, Muggeo M, Stephenson J, Idzior-Walus B. Diabetes Care; 1996 Jul; 19(7):689-97. PubMed ID: 8799621 [Abstract] [Full Text] [Related]
2. Plasma lipids and urinary albumin excretion rate in Type 1 diabetes mellitus: the EURODIAB IDDM Complications Study. Mattock MB, Cronin N, Cavallo-Perin P, Idzior-Walus B, Penno G, Bandinelli S, Standl E, Kofinis A, Fuller JH, EURODIAB IDDM Complications Study. Diabet Med; 2001 Jan; 18(1):59-67. PubMed ID: 11168343 [Abstract] [Full Text] [Related]
3. Cardiovascular disease in insulin dependent diabetes mellitus: similar rates but different risk factors in the US compared with Europe. Orchard TJ, Stevens LK, Forrest KY, Fuller JH. Int J Epidemiol; 1998 Dec; 27(6):976-83. PubMed ID: 10024191 [Abstract] [Full Text] [Related]
4. [Coronary risk factors in a group of patients with insulin dependent diabetes mellitus--examination of the EURODIAB IDDM Complications Study Krakow]. Idzior-Waluś B, Solnica B, Szopinska-Ciba L, Sieradzki J. Przegl Lek; 1994 Dec; 51(11):468-74. PubMed ID: 7871192 [Abstract] [Full Text] [Related]
5. Factors associated with plasma lipids and lipoproteins in type 1 diabetes mellitus: the EURODIAB IDDM Complications Study. Idzior-Walus B, Mattock MB, Solnica B, Stevens L, Fuller JH, EURODIAB IDDM Complications Study Group. Diabet Med; 2001 Oct; 18(10):786-96. PubMed ID: 11678968 [Abstract] [Full Text] [Related]
6. The relationship between socioeconomic status and diabetes control and complications in the EURODIAB IDDM Complications Study. Chaturvedi N, Stephenson JM, Fuller JH. Diabetes Care; 1996 May; 19(5):423-30. PubMed ID: 8732703 [Abstract] [Full Text] [Related]
7. Associations of fat and cholesterol intake with serum lipid levels and cardiovascular disease: the EURODIAB IDDM Complications Study. Toeller M, Buyken AE, Heitkamp G, Scherbaum WA, Krans HM, Fuller JH. Exp Clin Endocrinol Diabetes; 1999 May; 107(8):512-21. PubMed ID: 10612482 [Abstract] [Full Text] [Related]
8. A comparison of renal disease across two continents; the epidemiology of diabetes complications study and the EURODIAB IDDM Complications Study. Lloyd CE, Stephenson J, Fuller JH, Orchard TJ. Diabetes Care; 1996 Mar; 19(3):219-25. PubMed ID: 8742565 [Abstract] [Full Text] [Related]
9. Relationship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes: the EURODIAB Complications Study. Crook MA, Pickup JC, Lumb PJ, Giorgino F, Webb DJ, Fuller JH, EURODIAB IDDM Complications Study Group. Diabetes Care; 2001 Feb; 24(2):316-22. PubMed ID: 11213885 [Abstract] [Full Text] [Related]
10. Fibrinogen and von Willebrand factor in IDDM: relationships to lipid vascular risk factors, blood pressure, glycaemic control and urinary albumin excretion rate: the EURODIAB IDDM Complications Study. Greaves M, Malia RG, Goodfellow K, Mattock M, Stevens LK, Stephenson JM, Fuller JH. Diabetologia; 1997 Jun; 40(6):698-705. PubMed ID: 9222650 [Abstract] [Full Text] [Related]
11. The association of waist-hip ratio and risk factors for development of IDDM complications in an IDDM adult population. Stuhldreher WL, Orchard TJ, Ellis D. Diabetes Res Clin Pract; 1992 Aug; 17(2):99-109. PubMed ID: 1425153 [Abstract] [Full Text] [Related]
12. Fiber intake, serum cholesterol levels, and cardiovascular disease in European individuals with type 1 diabetes. EURODIAB IDDM Complications Study Group. Toeller M, Buyken AE, Heitkamp G, de Pergola G, Giorgino F, Fuller JH. Diabetes Care; 1999 Mar; 22 Suppl 2():B21-8. PubMed ID: 10097895 [Abstract] [Full Text] [Related]
13. Autonomic neuropathy is associated with increased cardiovascular risk factors: the EURODIAB IDDM Complications Study. Kempler P, Tesfaye S, Chaturvedi N, Stevens LK, Webb DJ, Eaton S, Kerényi Z, Tamás G, Ward JD, Fuller JH, EURODIAB IDDM Complications Study Group. Diabet Med; 2002 Nov; 19(11):900-9. PubMed ID: 12421426 [Abstract] [Full Text] [Related]
14. Microalbuminuria is not rare before 5 years of IDDM. EURODIAB IDDM Complications Study Group and the WHO Multinational Study of Vascular Disease in Diabetes Study Group. Stephenson JM, Fuller JH. J Diabetes Complications; 1994 Nov; 8(3):166-73. PubMed ID: 8086653 [Abstract] [Full Text] [Related]
15. Adverse effects of diabetes on multiple cardiovascular disease risk factors in women. The Strong Heart Study. Howard BV, Cowan LD, Go O, Welty TK, Robbins DC, Lee ET. Diabetes Care; 1998 Aug; 21(8):1258-65. PubMed ID: 9702430 [Abstract] [Full Text] [Related]
16. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Tesfaye S, Stevens LK, Stephenson JM, Fuller JH, Plater M, Ionescu-Tirgoviste C, Nuber A, Pozza G, Ward JD. Diabetologia; 1996 Nov; 39(11):1377-84. PubMed ID: 8933008 [Abstract] [Full Text] [Related]
17. Parental history of hypertension and parental history of diabetes and microvascular complications in insulin-dependent diabetes mellitus: the EURODIAB IDDM Complications Study. Roglic G, Colhoun HM, Stevens LK, Lemkes HH, Manes C, Fuller JH. Diabet Med; 1998 May; 15(5):418-26. PubMed ID: 9609365 [Abstract] [Full Text] [Related]
19. Low 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 levels are independently associated with macroalbuminuria, but not with retinopathy and macrovascular disease in type 1 diabetes: the EURODIAB prospective complications study. Engelen L, Schalkwijk CG, Eussen SJ, Scheijen JL, Soedamah-Muthu SS, Chaturvedi N, Fuller JH, Stehouwer CD. Cardiovasc Diabetol; 2015 May 30; 14():67. PubMed ID: 26025465 [Abstract] [Full Text] [Related]
20. Triglyceride, albuminuria and blood pressure are the major associations of non-fatal cardiovascular disease in Chinese type 2 diabetes. Ko GT, Chan JC, Chow CC, Yeung VT, Chan WB, So WY, Ma RC, Ozaki R, Cockram CS. Acta Diabetol; 2003 Jun 30; 40(2):80-4. PubMed ID: 12861405 [Abstract] [Full Text] [Related] Page: [Next] [New Search]